Bone Marrow-derived Cell Therapy Stimulates Endogenous Cardiomyocyte Progenitors and Promotes Cardiac Repair

Overview

Journal Cell Stem Cell

Publisher Cell Press

Specialty Cell Biology

Date 2011 Apr 9

PMID 21474103

Citations 198

Authors

Francesco S Loffredo

Matthew L Steinhauser

Joseph Gannon

Richard T Lee

Affiliations

Soon will be listed here.

Abstract

Cell therapy can improve cardiac function in animals and humans after injury, but the mechanism is unclear. We performed cell therapy experiments in genetically engineered mice that permanently express green fluorescent protein (GFP) only in cardiomyocytes after a pulse of 4-OH-tamoxifen. Myocardial infarction diluted the GFP(+) cardiomyocyte pool, indicating refreshment by non-GFP(+) progenitors. Cell therapy with bone marrow-derived c-kit(+) cells, but not mesenchymal stem cells, further diluted the GFP(+) pool, consistent with c-kit(+) cell-mediated augmentation of cardiomyocyte progenitor activity. This effect could not be explained by transdifferentiation to cardiomyocytes by exogenously delivered c-kit(+) cells or by cell fusion. Therapy with c-kit(+) cells but not mesenchymal stem cells improved cardiac function. These findings suggest that stimulation of endogenous cardiogenic progenitor activity is a critical mechanism of cardiac cell therapy.

Citing Articles

Application of mesenchymal stem cells in liver fibrosis and regeneration.

Liu Z, Ren J, Qiu C, Wang Y, Zhang T Liver Res. 2025; 8(4):246-258.

PMID: 39958916 PMC: 11771278. DOI: 10.1016/j.livres.2024.11.004.

Healing the Ischaemic Heart: A Critical Review of Stem Cell Therapies.

Tonkin D, Yee-Goh A, Katare R Rev Cardiovasc Med. 2024; 24(4):122.

PMID: 39076280 PMC: 11273058. DOI: 10.31083/j.rcm2404122.

Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells.

Clavellina D, Balkan W, Hare J Expert Opin Biol Ther. 2023; 23(10):951-967.

PMID: 37542462 PMC: 10837765. DOI: 10.1080/14712598.2023.2245329.

Uncovering the Heterogeneity of Cardiac Lin-KIT+ Cells: A scRNA-seq Study on the Identification of Subpopulations.

Shen Y, Kim I, Tang Y Stem Cells. 2023; 41(10):958-970.

PMID: 37539750 PMC: 11009691. DOI: 10.1093/stmcls/sxad057.

Bone marrow-derived c-kit positive stem cell administration protects against diabetes-induced nephropathy in a rat model by reversing PI3K/AKT/GSK-3β pathway and inhibiting cell apoptosis.

Ghaffari-Nasab A, Ghiasi F, Keyhanmanesh R, Roshangar L, Korjan E, Nazarpoor N Mol Cell Biochem. 2023; 479(3):603-615.

PMID: 37129768 DOI: 10.1007/s11010-023-04750-y.

References

Ceradini D, Kulkarni A, Callaghan M, Tepper O, Bastidas N, Kleinman M . Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004; 10(8):858-64. DOI: 10.1038/nm1075. View

Balsam L, Wagers A, Christensen J, Kofidis T, Weissman I, Robbins R . Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004; 428(6983):668-73. DOI: 10.1038/nature02460. View

Abdel-Latif A, Bolli R, Tleyjeh I, Montori V, Perin E, Hornung C . Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007; 167(10):989-97. DOI: 10.1001/archinte.167.10.989. View

Molkentin J, Lin Q, Duncan S, Olson E . Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 1997; 11(8):1061-72. DOI: 10.1101/gad.11.8.1061. View

Wu S, Fujiwara Y, Cibulsky S, Clapham D, Lien C, Schultheiss T . Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell. 2006; 127(6):1137-50. DOI: 10.1016/j.cell.2006.10.028. View

Segers V, Lee R . Stem-cell therapy for cardiac disease. Nature. 2008; 451(7181):937-42. DOI: 10.1038/nature06800. View

Ieda M, Fu J, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau B . Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 2010; 142(3):375-86. PMC: 2919844. DOI: 10.1016/j.cell.2010.07.002. View

Tang X, Rokosh G, Sanganalmath S, Yuan F, Sato H, Mu J . Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation. 2010; 121(2):293-305. PMC: 2814341. DOI: 10.1161/CIRCULATIONAHA.109.871905. View

Rota M, Kajstura J, Hosoda T, Bearzi C, Vitale S, Esposito G . Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A. 2007; 104(45):17783-8. PMC: 2077031. DOI: 10.1073/pnas.0706406104. View

10.

Lopez A, Mathers C, Ezzati M, Jamison D, Murray C . Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006; 367(9524):1747-57. DOI: 10.1016/S0140-6736(06)68770-9. View

11.

Murry C, Soonpaa M, Reinecke H, Nakajima H, Nakajima H, Rubart M . Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004; 428(6983):664-8. DOI: 10.1038/nature02446. View

12.

Laflamme M, Murry C . Regenerating the heart. Nat Biotechnol. 2005; 23(7):845-56. DOI: 10.1038/nbt1117. View

13.

Hare J, Traverse J, Henry T, Dib N, Strumpf R, Schulman S . A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009; 54(24):2277-86. PMC: 3580848. DOI: 10.1016/j.jacc.2009.06.055. View

14.

Koitabashi N, Bedja D, Zaiman A, Pinto Y, Zhang M, Gabrielson K . Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models. Circ Res. 2009; 105(1):12-5. PMC: 2747596. DOI: 10.1161/CIRCRESAHA.109.198416. View

15.

Saxena A, Fish J, White M, Yu S, Smyth J, Shaw R . Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation. 2008; 117(17):2224-31. PMC: 2743260. DOI: 10.1161/CIRCULATIONAHA.107.694992. View

16.

Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson S, Li B . Bone marrow cells regenerate infarcted myocardium. Nature. 2001; 410(6829):701-5. DOI: 10.1038/35070587. View

17.

Zaruba M, Theiss H, Vallaster M, Mehl U, Brunner S, David R . Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell. 2009; 4(4):313-23. DOI: 10.1016/j.stem.2009.02.013. View

18.

Hsieh P, Segers V, Davis M, Macgillivray C, Gannon J, Molkentin J . Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med. 2007; 13(8):970-4. PMC: 2754571. DOI: 10.1038/nm1618. View

19.

Nygren J, Jovinge S, Breitbach M, Sawen P, Roll W, Hescheler J . Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med. 2004; 10(5):494-501. DOI: 10.1038/nm1040. View

20.

Bergmann O, Bhardwaj R, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S . Evidence for cardiomyocyte renewal in humans. Science. 2009; 324(5923):98-102. PMC: 2991140. DOI: 10.1126/science.1164680. View